{"transactions":[{"id":1315950,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2025-01-03T21:25:58.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":7528,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":130906,"source":{"system":"sec-edgar","filing":"0001654954-25-000103","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000165495425000103/section16.xml","form_type":"4"}},{"id":1315949,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2025-01-03T21:25:58.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":1354,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":123378,"source":{"system":"sec-edgar","filing":"0001654954-25-000103","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000165495425000103/section16.xml","form_type":"4"}},{"id":1481066,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2024-06-13T21:36:07.000Z","date":"2024-06-11","kind":"grant","planned":false,"acquired":true,"shares":6273,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reporting person's previous Form 4 filed on June 6, 2024 inadvertently included an additional 66 shares of common stock in the total securities beneficially owned, which has been corrected in this Form 4."}],"balance_after":122024,"source":{"system":"sec-edgar","filing":"0001654954-24-007744","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000165495424007744/section16.xml","form_type":"4"}},{"id":1488721,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true}}],"security":"Nonstatutory Stock Option to Purchase Common Stock","published_at":"2024-06-06T22:28:46.000Z","date":"2024-06-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3626,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Issuer canceled options for an aggregate 13,200 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 10/21/2021, 7/28/2022, 12/16/2022, and 6/12/2023. In exchange for the canceled options, the Reporting Person received 30,010 shares of restricted stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The canceled option was issued pursuant to the 2021 Equity Incentive Plan on 6/12/2023 and vests as follows: 25% on the first three 3-month anniversaries of the grant, and 25% on the day prior to the Company's 2024 Annual Meeting of Stockholders, subject to the reporting person's continuous service on each applicable vesting date."}],"balance_after":0,"derivative":{"exercise_price":16.74,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":3626},"source":{"system":"sec-edgar","filing":"0001654954-24-007463","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000165495424007463/section16.xml","form_type":"4"}},{"id":1488720,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true}}],"security":"Nonstatutory Stock Option to Purchase Common Stock","published_at":"2024-06-06T22:28:46.000Z","date":"2024-06-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":707,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Issuer canceled options for an aggregate 13,200 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 10/21/2021, 7/28/2022, 12/16/2022, and 6/12/2023. In exchange for the canceled options, the Reporting Person received 30,010 shares of restricted stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The canceled options were fully vested."}],"balance_after":0,"derivative":{"exercise_price":17.16,"expiration_date":"2032-12-15","underlying":"Common Stock","underlying_shares":707},"source":{"system":"sec-edgar","filing":"0001654954-24-007463","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000165495424007463/section16.xml","form_type":"4"}},{"id":1488719,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true}}],"security":"Nonstatutory Stock Option to Purchase Common Stock","published_at":"2024-06-06T22:28:46.000Z","date":"2024-06-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2632,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Issuer canceled options for an aggregate 13,200 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 10/21/2021, 7/28/2022, 12/16/2022, and 6/12/2023. In exchange for the canceled options, the Reporting Person received 30,010 shares of restricted stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The canceled options were fully vested."}],"balance_after":0,"derivative":{"exercise_price":21.66,"expiration_date":"2032-07-27","underlying":"Common Stock","underlying_shares":2632},"source":{"system":"sec-edgar","filing":"0001654954-24-007463","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000165495424007463/section16.xml","form_type":"4"}},{"id":1488718,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true}}],"security":"Nonstatutory Stock Option to Purchase Common Stock","published_at":"2024-06-06T22:28:46.000Z","date":"2024-06-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4333,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Issuer canceled options for an aggregate 13,200 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 10/21/2021, 7/28/2022, 12/16/2022, and 6/12/2023. In exchange for the canceled options, the Reporting Person received 30,010 shares of restricted stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The canceled options were fully vested."}],"balance_after":0,"derivative":{"exercise_price":33,"expiration_date":"2031-10-20","underlying":"Common Stock","underlying_shares":4333},"source":{"system":"sec-edgar","filing":"0001654954-24-007463","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000165495424007463/section16.xml","form_type":"4"}},{"id":1488717,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true}}],"security":"Nonstatutory Stock Option to Purchase Common Stock","published_at":"2024-06-06T22:28:46.000Z","date":"2024-06-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1902,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"The share amount and exercise price have been adjusted from the amount reported on a previous Form 4 to reflect a 1 for 6 reverse stock split of the Issuer's stock in October 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Issuer canceled options for an aggregate 13,200 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 10/21/2021, 7/28/2022, 12/16/2022, and 6/12/2023. In exchange for the canceled options, the Reporting Person received 30,010 shares of restricted stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The canceled options were fully vested."}],"balance_after":0,"derivative":{"exercise_price":26.88,"expiration_date":"2031-10-11","underlying":"Common Stock","underlying_shares":1902},"source":{"system":"sec-edgar","filing":"0001654954-24-007463","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000165495424007463/section16.xml","form_type":"4"}},{"id":1488716,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-06T22:28:46.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":84941,"price":7.96,"value":676130.36,"ownership":{"direct":true},"balance_after":115817,"source":{"system":"sec-edgar","filing":"0001654954-24-007463","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000165495424007463/section16.xml","form_type":"4"}},{"id":1488715,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-06T22:28:46.000Z","date":"2024-06-05","kind":"grant","planned":false,"acquired":true,"shares":30010,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Issuer canceled options for an aggregate 13,200 shares of the Issuer's common stock granted to the Reporting Person on 10/12/2021, 10/21/2021, 7/28/2022, 12/16/2022, and 6/12/2023. In exchange for the canceled options, the Reporting Person received 30,010 shares of restricted stock."}],"balance_after":30876,"source":{"system":"sec-edgar","filing":"0001654954-24-007463","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000165495424007463/section16.xml","form_type":"4"}},{"id":1856271,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true}}],"security":"Nonstatutory Stock Option to Purchase Common Stock","published_at":"2023-06-14T21:05:29.000Z","date":"2023-06-12","kind":"grant","planned":false,"acquired":true,"shares":21756,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 25% on the first three 3-month anniversaries of the grant, and 25% on the day prior to the Company's 2024 Annual Meeting of Stockholders, subject to the reporting person's continuous service on each applicable vesting date."}],"balance_after":21756,"derivative":{"exercise_price":2.79,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":21756},"source":{"system":"sec-edgar","filing":"0001654954-23-008022","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000165495423008022/section16.xml","form_type":"4"}},{"id":2079009,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-12-21T21:39:20.000Z","date":"2022-12-19","kind":"purchase","acquired":true,"shares":300,"price":2.64,"value":792.0,"ownership":{"direct":true},"balance_after":5198,"source":{"system":"sec-edgar","filing":"0001654954-22-016814","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000165495422016814/section16.xml","form_type":"4"}},{"id":2080094,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true}}],"security":"Nonstatutory Stock Option to Purchase Common Stock","published_at":"2022-12-20T21:15:30.000Z","date":"2022-12-16","kind":"grant","acquired":true,"shares":4244,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was issued pursuant to the 2021 Equity Incentive Plan and vested immediately upon grant."}],"balance_after":4244,"derivative":{"exercise_price":2.86,"expiration_date":"2032-12-15","underlying":"Common Stock","underlying_shares":4244},"source":{"system":"sec-edgar","filing":"0001654954-22-016733","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000165495422016733/section16.xml","form_type":"4"}},{"id":2092453,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true}}],"security":"Nonstatutory Stock Option to Purchase Common Stock","published_at":"2022-12-08T21:18:02.000Z","date":"2022-07-28","kind":"grant","acquired":true,"shares":15797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This amendment is being filed solely to correct the date of the earliest transaction reported to July 28, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 25% on the first three 3-month anniversaries of the grant, and 25% on the day prior to the Company's 2023 Annual Meeting of Stockholders, subject to the reporting person's continuous service on each applicable vesting date."}],"balance_after":15797,"derivative":{"exercise_price":3.61,"expiration_date":"2032-07-27","underlying":"Common Stock","underlying_shares":15797},"source":{"system":"sec-edgar","filing":"0001654954-22-016254","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000165495422016254/section16.xml","form_type":"4/A","original_submission_date":"2022-08-01"}},{"id":2199281,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true}}],"security":"Nonstatutory Stock Option to Purchase Common Stock","published_at":"2022-08-01T20:22:46.000Z","date":"2022-07-28","kind":"grant","acquired":true,"shares":15797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 25% on the first three 3-month anniversaries of the grant, and 25% on the day prior to the Company's 2023 Annual Meeting of Stockholders, subject to the reporting person's continuous service on each applicable vesting date."}],"balance_after":15797,"derivative":{"exercise_price":3.61,"expiration_date":"2032-07-27","underlying":"Common Stock","underlying_shares":15797},"source":{"system":"sec-edgar","filing":"0001654954-22-010396","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000165495422010396/section16.xml","form_type":"4"}},{"id":2535730,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true}}],"security":"Nonstatutory Stock Option to Purchase Common Stock","published_at":"2021-10-25T23:01:42.000Z","date":"2021-10-21","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 25% upon acceptance of the grant, 25% on each of the next two 4-month anniversaries of the grant, and 25% on the day prior to the Company's 2022 Annual Meeting of Stockholders."}],"balance_after":26000,"derivative":{"exercise_price":5.5,"expiration_date":"2031-10-20","underlying":"Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001654954-21-011335","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000165495421011335/section16.xml","form_type":"4"}},{"id":2541875,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true}}],"security":"Nonstatutory Stock Option to Purchase Common Stock","published_at":"2021-10-16T01:18:51.000Z","date":"2021-10-12","kind":"grant","acquired":true,"shares":11416,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 25% on the first three 3-month anniversaries of the grant, and 25% on the day prior to the Company's 2022 Annual General Meeting of Stockholders, subject to the reporting person's continuous service on each applicable vesting date."}],"balance_after":11416,"derivative":{"exercise_price":4.48,"expiration_date":"2031-10-11","underlying":"Common Stock","underlying_shares":11416},"source":{"system":"sec-edgar","filing":"0001654954-21-011168","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000165495421011168/section16.xml","form_type":"4"}},{"id":2681371,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Warrant","published_at":"2021-06-04T19:53:12.000Z","date":"2021-06-02","kind":"purchase","acquired":true,"shares":400,"price":0.01,"value":4.0,"ownership":{"direct":true},"balance_after":400,"derivative":{"exercise_price":5.5,"exercise_date":"2021-06-02","expiration_date":"2026-06-02","underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001078782-21-000536","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000107878221000536/primary_doc.xml","form_type":"4"}},{"id":2681370,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-04T19:53:12.000Z","date":"2021-06-02","kind":"purchase","acquired":true,"shares":400,"price":4.99,"value":1996.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The share amount has been adjusted to reflect the reverse stock split effective on May 28, 2021 whereby each eighty shares of common stock issued and outstanding prior to the split were combined and converted into one share of common stock."}],"balance_after":4898,"source":{"system":"sec-edgar","filing":"0001078782-21-000536","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000107878221000536/primary_doc.xml","form_type":"4"}},{"id":2963151,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Warrant","published_at":"2020-12-01T23:17:12.000Z","date":"2020-09-30","kind":"tax_withholding","acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The warrants were issued to the reporting person as compensation for acting as a director."}],"balance_after":500000,"derivative":{"exercise_price":0.12,"exercise_date":"2020-09-30","expiration_date":"2025-09-30","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001078782-20-000933","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000107878220000933/primary_doc.xml","form_type":"4"}},{"id":2963150,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Warrant","published_at":"2020-12-01T23:17:12.000Z","date":"2020-08-18","kind":"exercise","acquired":false,"shares":250000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":250000,"derivative":{"exercise_price":0.1,"exercise_date":"2015-09-10","expiration_date":"2020-09-10","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001078782-20-000933","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000107878220000933/primary_doc.xml","form_type":"4"}},{"id":2963149,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-01T23:17:12.000Z","date":"2020-08-18","kind":"tax_withholding","acquired":false,"shares":208333,"price":0.12,"value":24999.96,"ownership":{"direct":true},"balance_after":359849,"source":{"system":"sec-edgar","filing":"0001078782-20-000933","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000107878220000933/primary_doc.xml","form_type":"4"}},{"id":2963148,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-01T23:17:12.000Z","date":"2020-08-18","kind":"exercise","acquired":true,"shares":250000,"price":0.1,"value":25000.0,"ownership":{"direct":true},"balance_after":568182,"source":{"system":"sec-edgar","filing":"0001078782-20-000933","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000107878220000933/primary_doc.xml","form_type":"4"}},{"id":3170375,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Warrant","published_at":"2020-04-24T15:56:36.000Z","date":"2020-04-15","kind":"exercise","acquired":false,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The warrants were exercised utilizing the \"cashless\" exercise feature."}],"balance_after":500000,"derivative":{"exercise_price":0.07,"exercise_date":"2017-09-11","expiration_date":"2022-09-11","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001078782-20-000283","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000107878220000283/primary_doc.xml","form_type":"4"}},{"id":3170374,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Warrant","published_at":"2020-04-24T15:56:36.000Z","date":"2020-04-15","kind":"exercise","acquired":false,"shares":250000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The warrants were exercised utilizing the \"cashless\" exercise feature."}],"balance_after":250000,"derivative":{"exercise_price":0.05,"exercise_date":"2016-09-10","expiration_date":"2021-09-10","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001078782-20-000283","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000107878220000283/primary_doc.xml","form_type":"4"}},{"id":3170373,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Warrant","published_at":"2020-04-24T15:56:36.000Z","date":"2019-09-26","kind":"grant","acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The warrants were issued to the reporting person as compensation for acting as a director."}],"balance_after":500000,"derivative":{"exercise_price":0.08,"exercise_date":"2019-09-26","expiration_date":"2024-09-26","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001078782-20-000283","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000107878220000283/primary_doc.xml","form_type":"4"}},{"id":3170372,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Warrant","published_at":"2020-04-24T15:56:36.000Z","date":"2018-09-28","kind":"grant","acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The warrants were issued to the reporting person as compensation for acting as a director."}],"balance_after":500000,"derivative":{"exercise_price":0.14,"exercise_date":"2018-09-28","expiration_date":"2023-09-26","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001078782-20-000283","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000107878220000283/primary_doc.xml","form_type":"4"}},{"id":3170371,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Warrant","published_at":"2020-04-24T15:56:36.000Z","date":"2017-09-11","kind":"grant","acquired":true,"shares":500000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The warrants were issued to the reporting person as compensation for acting as a director."}],"balance_after":500000,"derivative":{"exercise_price":0.07,"exercise_date":"2017-09-11","expiration_date":"2022-09-11","underlying":"Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001078782-20-000283","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000107878220000283/primary_doc.xml","form_type":"4"}},{"id":3170370,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Warrant","published_at":"2020-04-24T15:56:36.000Z","date":"2016-09-10","kind":"grant","acquired":true,"shares":250000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The warrants were issued to the reporting person as compensation for acting as a director."}],"balance_after":250000,"derivative":{"exercise_price":0.05,"exercise_date":"2016-09-10","expiration_date":"2021-09-10","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001078782-20-000283","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000107878220000283/primary_doc.xml","form_type":"4"}},{"id":3170369,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Purchase Warrant","published_at":"2020-04-24T15:56:36.000Z","date":"2015-09-10","kind":"grant","acquired":true,"shares":250000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The warrants were issued to the reporting person as compensation for acting as a director."}],"balance_after":250000,"derivative":{"exercise_price":0.1,"exercise_date":"2015-09-10","expiration_date":"2020-09-10","underlying":"Common Stock","underlying_shares":250000},"source":{"system":"sec-edgar","filing":"0001078782-20-000283","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000107878220000283/primary_doc.xml","form_type":"4"}},{"id":3170368,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-24T15:56:36.000Z","date":"2020-04-15","kind":"exercise","acquired":true,"shares":181818,"price":0.07,"value":12727.26,"ownership":{"direct":true},"balance_after":318182,"source":{"system":"sec-edgar","filing":"0001078782-20-000283","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000107878220000283/primary_doc.xml","form_type":"4"}},{"id":3170367,"issuer":{"id":9611,"kind":"organization","name":"Zivo Bioscience, Inc."},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-24T15:56:36.000Z","date":"2020-04-15","kind":"exercise","acquired":true,"shares":136364,"price":0.05,"value":6818.2,"ownership":{"direct":true},"balance_after":136364,"source":{"system":"sec-edgar","filing":"0001078782-20-000283","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1101026/000107878220000283/primary_doc.xml","form_type":"4"}},{"id":4083943,"issuer":{"id":169957,"kind":"organization","name":"REPROS THERAPEUTICS INC.","symbol":"RPRX"},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2018-01-31T09:59:34.000Z","date":"2018-01-31","kind":"disposition_to_issuer","acquired":false,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to purchase Shares (a \"Company Option\") that was then outstanding and unexercised, whether or not vested and which had a per-Share exercise price less than the Closing Amount (each, an \"In the Money Option\"), was cancelled and converted into the right to receive (i) a cash payment equal to (A) the excess, if any, of (x) the Closing Amount over (y) the exercise price payable per Share under such In the Money Option, multiplied by (B) the total number of Shares subject to such In the Money Option immediately prior to the Effective Time. At the Effective Time, each Company Option other than an In the Money Option that was then outstanding and unexercised, whether or not vested (each, an \"Out of the Money Option\"), was cancelled at the Effective Time without any consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the Merger Agreement, each option to purchase Shares (a \"Company Option\") that was then outstanding and unexercised, whether or not vested and which had a per-Share exercise price less than the Closing Amount (each, an \"In the Money Option\"), was cancelled and converted into the right to receive (i) a cash payment equal to (A) the excess, if any, of (x) the Closing Amount over (y) the exercise price payable per Share under such In the Money Option, multiplied by (B) the total number of Shares subject to such In the Money Option immediately prior to the Effective Time. At the Effective Time, each Company Option other than an In the Money Option that was then outstanding and unexercised, whether or not vested (each, an \"Out of the Money Option\"), was cancelled at the Effective Time without any consideration payable therefor."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Shares subject to this option were fully vested immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":0.32,"expiration_date":"2027-09-15","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001144204-18-004781","document":"tv484342_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/897075/000114420418004781/tv484342_4.xml","form_type":"4"}},{"id":4083942,"issuer":{"id":169957,"kind":"organization","name":"REPROS THERAPEUTICS INC.","symbol":"RPRX"},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-31T09:59:34.000Z","date":"2018-01-31","kind":"disposition_to_issuer","acquired":false,"shares":27779,"price":0.67,"value":18611.93,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Consists of restricted stock units. Pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated December 11, 2018, by and among Repros Therapeutics Inc. (the \"Issuer\"), Allergan Sales, LLC (\"Parent\") and Celestial Merger Sub, Inc. (\"Purchaser\"), pursuant to which Purchaser was merged with and into Issuer (the \"Merger\"), each outstanding restricted stock unit and any associated rights to the issuance of shares of the Issuer's common stock, par value $0.001 per share (the \"Shares\") upon the achievement of Issuer performance goals (the \"Issuer RSUs\") under the Issuer's equity plans that was not then vested was cancelled, (continued in Footnote 2)"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(continued from Footnote 1) and the holder of such cancelled Issuer RSUs became entitled to receive, in exchange therefor, an amount in cash equal to the product of (x) the total number of Shares subject to (or deliverable under) such Issuer RSUs immediately prior to the effective time of the Merger (the \"Effective Time\") (determined after giving effect to the accelerated vesting and deemed achievement at maximum applicable performance levels) multiplied by (y) $0.67 in cash (the \"Closing Amount\"). These restricted stock units were fully vested immediately prior to the Effective Time."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-18-004781","document":"tv484342_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/897075/000114420418004781/tv484342_4.xml","form_type":"4"}},{"id":4083941,"issuer":{"id":169957,"kind":"organization","name":"REPROS THERAPEUTICS INC.","symbol":"RPRX"},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-31T09:59:34.000Z","date":"2018-01-29","kind":"other","acquired":false,"shares":12221,"price":0.67,"value":8188.07,"ownership":{"direct":true},"balance_after":27779,"source":{"system":"sec-edgar","filing":"0001144204-18-004781","document":"tv484342_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897075/000114420418004781/tv484342_4.xml","form_type":"4"}},{"id":4207643,"issuer":{"id":169957,"kind":"organization","name":"REPROS THERAPEUTICS INC.","symbol":"RPRX"},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2017-09-18T16:02:31.000Z","date":"2017-09-15","kind":"grant","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Received as compensation for service on Board of Directors of issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option shares shall vest in equal monthly installments over the first twelve months after the date of grant."}],"balance_after":5000,"derivative":{"exercise_price":0.32,"expiration_date":"2027-09-15","underlying":"Common","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001144204-17-048489","document":"v475367_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897075/000114420417048489/v475367_4.xml","form_type":"4"}},{"id":4446698,"issuer":{"id":169957,"kind":"organization","name":"REPROS THERAPEUTICS INC.","symbol":"RPRX"},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-02-15T16:28:42.000Z","date":"2017-02-13","kind":"grant","acquired":true,"shares":40000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Consists of Restricted Stock Units (RSUs), representing the right to receive one share of the issuer's common stock for each vested RSU, that were awarded on February 13, 2017 as compensation to non-employee members of the Board of Directors.  The RSUs shall vest in thirty-six (36) equal increments on the last day of each calendar month from February 2017 through January 2020."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001144204-17-009366","document":"v459723_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897075/000114420417009366/v459723_4.xml","form_type":"4"}},{"id":4543752,"issuer":{"id":169957,"kind":"organization","name":"REPROS THERAPEUTICS INC.","symbol":"RPRX"},"owners":[{"id":84544,"kind":"person","name":"Masterson Nola E","position":1,"cik":"0001305231","reported_name":"Masterson Nola E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-23T16:07:16.000Z","date":"2016-11-21","kind":"sale","acquired":false,"shares":3305,"price":1.95,"value":6444.75,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001144204-16-136348","document":"v453807_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/897075/000114420416136348/v453807_4.xml","form_type":"4"}}]}